Accretion Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Total Revenue Annual | 57.38 | 13.35 |
| Operating Expenses Annual | 45.50 | 10.79 |
| Operating Profit Annual | 11.98 | 2.62 |
| Interest Annual | 1.44 | 0.40 |
| Depreciation | 0.77 | 0.22 |
| Net Profit Annual | 6.79 | 1.49 |
| Tax Annual | 2.97 | 0.50 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 57.38 |
| Operating Expenses Annual | 45.50 |
| Operating Profit Annual | 11.98 |
| Interest Annual | 1.44 |
| Depreciation | 0.77 |
| Net Profit Annual | 6.79 |
| Tax Annual | 2.97 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Cash Flow at the Beginning | 0.09 | TBA |
| Cash Flow from Operations | 5.75 | -11.51 |
| Cash Flow from Investing | -1.61 | -5.48 |
| Cash Flow from Financing | -4.18 | 17.08 |
| Cash Flow at the End | 0.05 | 0.09 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | 5.75 |
| Cash Flow from Investing | -1.61 |
| Cash Flow from Financing | -4.18 |
| Cash Flow at the End | 0.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| PBDIT Margin (%) | 20.88 | 19.63 |
| PBIT Margin (%) | 19.54 | 17.98 |
| PBT Margin (%) | 5.98 | -26.81 |
| Net PROFIT Margin (%) | 11.83 | 11.16 |
| Return On Networth / Equity (%) | 65.35 | 27.14 |
| Return On Networth /Employed (%) | 46.32 | 12.60 |
| Return On Assets (%) | 28.05 | 7.81 |
| Total Debt / Equity (X) | 1.33 | 2.46 |
| Asset Turnover Ratio (%) | 2.37 | 0.70 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 20.88 |
| PBIT Margin (%) | 19.54 |
| PBT Margin (%) | 5.98 |
| Net PROFIT Margin (%) | 11.83 |
| Return On Networth / Equity (%) | 65.35 |
| Return On Networth /Employed (%) | 46.32 |
| Return On Assets (%) | 28.05 |
| Total Debt / Equity (X) | 1.33 |
| Asset Turnover Ratio (%) | 2.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Fixed Assets Annual | 6.09 | 5.25 |
| Total Current Assets Annual | 33.55 | 22.05 |
| Non Current Assets Annual | 6.33 | 5.39 |
| Total Shareholders Funds Annual | 15.29 | 5.49 |
| Total Assets Annual | 39.87 | 27.44 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 6.09 |
| Total Current Assets Annual | 33.55 |
| Non Current Assets Annual | 6.33 |
| Total Shareholders Funds Annual | 15.29 |
| Total Assets Annual | 39.87 |
No Data Availabe
